These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 35892283)

  • 1. Cannabis Legalization and cannabis-Related Hospitalizations in Ontario, Canada.
    Kim C; Chum A; Nielsen A; MacMaster F; Rittenbach K; Allin S; O'Campo P; Kirst M; Hamilton H
    Can J Psychiatry; 2023 Jan; 68(1):67-70. PubMed ID: 35892283
    [No Abstract]   [Full Text] [Related]  

  • 2. Associations between recreational cannabis legalization and cannabis-related emergency department visits by age, gender, and geographic status in Ontario, Canada: An interrupted time series study.
    Kim C; Chum A; Nielsen A; Allin S; Penney TL; Rittenbach K; MacMaster FP; O'Campo P
    PLoS One; 2022; 17(10):e0268718. PubMed ID: 36288275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of non-medical cannabis legalization with market restrictions on health service use and incident cases of psychotic disorder in Ontario, Canada.
    Anderson KK; Rodrigues R; Le B; Mamun M; Archie S; Edwards J; Elton-Marshall T; Gilliland J; Myran DT; Palaniyappan L; Perlman CM; Seabrook JA; Murray RM; Shariff SZ
    Int J Drug Policy; 2024 Jan; 123():104285. PubMed ID: 38071933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabis legalization and cannabis use, daily cannabis use and cannabis-related problems among adults in Ontario, Canada (2001-2019).
    Imtiaz S; Nigatu YT; Ali F; Douglas L; Hamilton HA; Rehm J; Rueda S; Schwartz RM; Wells S; Elton-Marshall T
    Drug Alcohol Depend; 2023 Mar; 244():109765. PubMed ID: 36652851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in Rates of Hospitalizations due to Cannabis Harms in Ontario, Canada Before the Legalization of Nonmedical Cannabis: Retrospective Population-level Study Between 2003 and 2017.
    Zygmunt A; Tanuseputro P; Brown C; Lima I; Rhodes E; Myran D
    J Addict Med; 2022 May-Jun 01; 16(3):e177-e184. PubMed ID: 34387560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabis-related Hospitalizations Among Youth in Canada Before and After Cannabis Legalization.
    Auger N; Luu TM; Ayoub A; Bilodeau-Bertrand M; Lo E; Low N
    J Addict Med; 2021 May-Jun 01; 15(3):245-247. PubMed ID: 33060465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The implementation and public health impacts of cannabis legalization in Canada: a systematic review.
    Hall W; Stjepanović D; Dawson D; Leung J
    Addiction; 2023 Nov; 118(11):2062-2072. PubMed ID: 37380613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between recreational cannabis legalization, commercialization and cannabis-attributable emergency department visits in Ontario, Canada: an interrupted time-series analysis.
    Myran DT; Pugliese M; Tanuseputro P; Cantor N; Rhodes E; Taljaard M
    Addiction; 2022 Jul; 117(7):1952-1960. PubMed ID: 35170149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canada's cannabis legalization and drivers' traffic-injury presentations to emergency departments in Ontario and Alberta, 2015-2019.
    Callaghan RC; Sanches M; Vander Heiden J; Asbridge M; Stockwell T; Macdonald S; Peterman BH; Kish SJ
    Drug Alcohol Depend; 2021 Nov; 228():109008. PubMed ID: 34508959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the public health impact of cannabis legalization in Canada: core outcome indicators towards an 'index' for monitoring and evaluation.
    Fischer B; Russell C; Rehm J; Leece P
    J Public Health (Oxf); 2019 Jun; 41(2):412-421. PubMed ID: 29860521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations Between Canada's Cannabis Legalization and Emergency Department Presentations for Transient Cannabis-Induced Psychosis and Schizophrenia Conditions: Ontario and Alberta, 2015-2019.
    Callaghan RC; Sanches M; Murray RM; Konefal S; Maloney-Hall B; Kish SJ
    Can J Psychiatry; 2022 Aug; 67(8):616-625. PubMed ID: 35019734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Legalization as more effective control? Parallels between the end of alcohol prohibition (1927) and the legalization of cannabis (2018) in Ontario, Canada.
    Crépault JF; Rehm J; Room R
    Int J Drug Policy; 2021 Nov; 97():103367. PubMed ID: 34311148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in Emergency Department Visits for Cannabis Hyperemesis Syndrome Following Recreational Cannabis Legalization and Subsequent Commercialization in Ontario, Canada.
    Myran DT; Roberts R; Pugliese M; Taljaard M; Tanuseputro P; Pacula RL
    JAMA Netw Open; 2022 Sep; 5(9):e2231937. PubMed ID: 36112372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute cannabis intoxication in the emergency department: the effect of legalization.
    Baraniecki R; Panchal P; Malhotra DD; Aliferis A; Zia Z
    BMC Emerg Med; 2021 Mar; 21(1):32. PubMed ID: 33731003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug use in Canadian patients with trauma after cannabis legalization.
    Ball IM; Priestap F; Parry N; Pace J; Vogt KN
    Can J Surg; 2021 Jul; 64(4):E403-E406. PubMed ID: 34296708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Where does the high road lead?" Potential implications of cannabis legalization for pediatric injuries in Canada.
    Karbakhsh M; Smith J; Pike I
    Can J Public Health; 2018 Dec; 109(5-6):752-755. PubMed ID: 30264194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabis use and misuse in the year following recreational cannabis legalization in Canada: A longitudinal observational cohort study of community adults in Ontario.
    Turna J; Belisario K; Balodis I; Van Ameringen M; Busse J; MacKillop J
    Drug Alcohol Depend; 2021 Aug; 225():108781. PubMed ID: 34098383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric Hospitalizations for Unintentional Cannabis Poisonings and All-Cause Poisonings Associated With Edible Cannabis Product Legalization and Sales in Canada.
    Myran DT; Tanuseputro P; Auger N; Konikoff L; Talarico R; Finkelstein Y
    JAMA Health Forum; 2023 Jan; 4(1):e225041. PubMed ID: 36637814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabis use in patients treated for opioid use disorder pre- and post-recreational cannabis legalization in Canada.
    Rosic T; Sanger N; Panesar B; Foster G; Marsh DC; Rieb L; Thabane L; Worster A; Samaan Z
    Subst Abuse Treat Prev Policy; 2021 Apr; 16(1):34. PubMed ID: 33849580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An overview of select cannabis use and supply indicators pre- and post-legalization in Canada.
    Fischer B; Lee A; Robinson T; Hall W
    Subst Abuse Treat Prev Policy; 2021 Oct; 16(1):77. PubMed ID: 34620191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.